Black Diamond Therapeutics rakes in $85 mln Series C

Cambridge, Massachusetts-based Black Diamond Therapeutics, Inc., a precision oncology medicine company, has raised $85 million in Series C financing.

Cambridge, Massachusetts-based Black Diamond Therapeutics, Inc., a precision oncology medicine company, has raised $85 million in Series C financing. Boxer Capital of the Tavistock Group led the round.

Source: Press Release